"However, the phase 2 results showed the primary endpoint in reduction in inflammatory lesions did not achieve statistical significance ..."
This statement refers to the Australian results for Phase 2 BTX 1503 and is
a serious departure from the truth.
- Forums
- ASX - By Stock
- BOT
- Objective Views on Lead product: BTX 1503 (Acne)
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
1.52%
!
16.3¢

Objective Views on Lead product: BTX 1503 (Acne), page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.3¢ |
Change
-0.003(1.52%) |
Mkt cap ! $318.6M |
Open | High | Low | Value | Volume |
16.5¢ | 17.0¢ | 16.0¢ | $1.161M | 7.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
99 | 5237772 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 674507 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
99 | 5237772 | 0.160 |
42 | 2607371 | 0.155 |
65 | 2305364 | 0.150 |
33 | 2199807 | 0.145 |
87 | 3834363 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 674507 | 26 |
0.170 | 2471980 | 36 |
0.175 | 2594541 | 35 |
0.180 | 3124513 | 60 |
0.185 | 1731895 | 29 |
Last trade - 14.22pm 29/07/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |